Profund Advisors LLC Charles River Laboratories International, Inc. Transaction History

Profund Advisors LLC

$2.59 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$203.52 - $273.43 $18,723 - $25,155	-92 Reduced 10.47%	787 $213,000
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $144,613 - $209,940	879 New	879 $207,000
Q4 2022 Feb 02, 2023	BUY	$197.11 - $250.07 $35,085 - $44,512	178 Added 3.04%	6,036 $1.31 Million
Q3 2022 Nov 04, 2022	SELL	$182.44 - $250.54 $43,785 - $60,129	-240 Reduced 3.94%	5,858 $1.15 Million
Q2 2022 Aug 01, 2022	SELL	$204.13 - $302.4 $122,069 - $180,835	-598 Reduced 8.93%	6,098 $1.31 Million
Q1 2022 May 10, 2022	SELL	$255.51 - $362.11 $187,288 - $265,426	-733 Reduced 9.87%	6,696 $1.9 Million
Q4 2021 Feb 08, 2022	SELL	$351.38 - $448.68 $406,898 - $519,571	-1,158 Reduced 13.49%	7,429 $2.8 Million
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $145,702 - $179,195	-391 Reduced 4.36%	8,587 $3.54 Million
Q2 2021 Aug 12, 2021	SELL	$294.17 - $371.65 $726,599 - $917,975	-2,470 Reduced 21.58%	8,978 $3.32 Million
Q1 2021 May 14, 2021	SELL	$249.67 - $299.48 $609,943 - $731,629	-2,443 Reduced 17.59%	11,448 $3.32 Million
Q4 2020 Feb 09, 2021	BUY	$222.0 - $252.62 $227,994 - $259,440	1,027 Added 7.98%	13,891 $3.47 Million
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $29,494 - $38,043	-168 Reduced 1.29%	12,864 $2.91 Million
Q2 2020 Aug 03, 2020	BUY	$118.84 - $189.72 $257,645 - $411,312	2,168 Added 19.96%	13,032 $2.27 Million
Q1 2020 May 15, 2020	SELL	$98.9 - $178.34 $481,445 - $868,159	-4,868 Reduced 30.94%	10,864 $1.37 Million
Q4 2019 Feb 18, 2020	BUY	$126.05 - $152.76 $147,478 - $178,729	1,170 Added 8.03%	15,732 $2.4 Million
Q3 2019 Nov 12, 2019	SELL	$125.07 - $143.67 $178,850 - $205,448	-1,430 Reduced 8.94%	14,562 $1.93 Million
Q2 2019 Aug 13, 2019	SELL	$123.4 - $148.55 $208,422 - $250,900	-1,689 Reduced 9.55%	15,992 $2.27 Million
Q1 2019 May 15, 2019	BUY	$104.82 - $146.73 $157,439 - $220,388	1,502 Added 9.28%	17,681 $2.57 Million
Q4 2018 Feb 14, 2019	SELL	$105.09 - $137.23 $591,971 - $773,016	-5,633 Reduced 25.83%	16,179 $1.83 Million
Q3 2018 Nov 13, 2018	BUY	$112.11 - $134.54 $76,683 - $92,025	684 Added 3.24%	21,812 $2.94 Million
Q2 2018 Aug 13, 2018	SELL	$102.37 - $117.25 $50,877 - $58,273	-497 Reduced 2.3%	21,128 $2.37 Million
Q1 2018 May 14, 2018	SELL	$98.19 - $115.2 $61,859 - $72,576	-630 Reduced 2.83%	21,625 $2.31 Million
Q4 2017 Feb 14, 2018	SELL	$100.43 - $118.09 $224,059 - $263,458	-2,231 Reduced 9.11%	22,255 $2.44 Million
Q3 2017 Nov 13, 2017	BUY	$96.72 - $109.26 $174,096 - $196,668	1,800 Added 7.93%	24,486 $2.65 Million
Q2 2017 Aug 11, 2017	BUY	N/A	22,686	22,686 $2.3 Million

Others Institutions Holding CRL

# of Institutions

691

Shares Held

51.6M

Call Options Held

259K

Put Options Held

463K

Vanguard Group Inc Valley Forge, PA

6.1M
Shares

$1 Billion
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$838 Million
0.02% of portfolio
Wellington Management Group LLP Boston, MA

3.74M
Shares

$616 Million
0.13% of portfolio
State Street Corp Boston, MA

2.13M
Shares

$351 Million
0.02% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.94M
Shares

$320 Million
0.87% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Account